{"DataElement":{"publicId":"13378563","version":"1","preferredName":"Stem Cell Transplant Conditioning Type","preferredDefinition":"The type of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, administered to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.","longName":"13370625v1.00:13374548v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13370625","version":"1","preferredName":"Stem Cell Transplant Conditioning","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.:Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection).","longName":"2659877v1.00:2778342v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2659877","version":"1","preferredName":"Stem Cell Transplantation","preferredDefinition":"A method of replacing the immature blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells.  The stem cells are given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.","longName":"C15431","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BBDBD7-E7FD-4A2E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778342","version":"1","preferredName":"Transplant Conditioning","preferredDefinition":"Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection).","longName":"C64468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transplant Conditioning","conceptCode":"C64468","definition":"Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55729885-B281-2112-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F99FB8D4-5EA6-0872-E053-731AD00A90A6","latestVersionIndicator":"Yes","beginDate":"2023-04-18","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-18","modifiedBy":"JKNABLE","dateModified":"2023-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13374548","version":"1","preferredName":"Transplant Conditioning Type","preferredDefinition":"Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection)._Something distinguishable as an identifiable class based on common qualities.","longName":"13374548v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Myeloablative","valueDescription":null,"ValueMeaning":{"publicId":"2568580","version":"1","preferredName":"Myeloablative","longName":"2568580v1.00","preferredDefinition":"A conditioning regimen with high doses of chemotherapy or radiation to eliminate host hematopoietic stem cells prior to restitution via transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloablative Conditioning","conceptCode":"C131679","definition":"A conditioning regimen with high doses of chemotherapy or radiation to eliminate host hematopoietic stem cells prior to restitution via transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"MMADDINENI","dateModified":"2022-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B0D0FD-9EEF-0148-E053-731AD00AA948","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Non-Myeloablative","valueDescription":null,"ValueMeaning":{"publicId":"13328603","version":"1","preferredName":"Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation","longName":"13328603v1.00","preferredDefinition":"A modification of the standard method of allogeneic hematopoietic stem cell transplantation developed to allow for the therapy to be extended to a patient population that is unable to tolerate treatment with the conventional procedure due to its toxicity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation","conceptCode":"C62714","definition":"A modification of the standard method of allogeneic hematopoietic stem cell transplantation developed to allow for the therapy to be extended to a patient population that is unable to tolerate treatment with the conventional procedure due to its toxicity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8B17744-90D0-24B7-E053-731AD00AEC4F","latestVersionIndicator":"Yes","beginDate":"2023-04-06","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-06","modifiedBy":"FINCHAMB","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B0D0FD-9EF0-0148-E053-731AD00AA948","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Reduced Intensity Conditioning/Reduced Toxicity Conditioning","valueDescription":null,"ValueMeaning":{"publicId":"4383037","version":"1","preferredName":"Reduced Intensity","longName":"4383037v1.00","preferredDefinition":"A method of preparation for stem cell transplant that uses less than standard doses of chemotherapy and radiation prior to the transfer of stem cells, with the goal of providing protection against graft vs. host disease, while simultaneously minimizing the toxic effects of the conditioning treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced-Intensity Transplant Conditioning Procedure","conceptCode":"C116471","definition":"A method of preparation for stem cell transplant that uses less than standard doses of chemotherapy and radiation prior to the transfer of stem cells, with the goal of providing protection against graft vs. host disease, while simultaneously minimizing the toxic effects of the conditioning treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9BFA-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"MMADDINENI","dateModified":"2022-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B0D0FD-9EF1-0148-E053-731AD00AA948","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B0D0FD-9EF2-0148-E053-731AD00AA948","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B0D0FD-9EF3-0148-E053-731AD00AA948","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B0D0FD-9EF4-0148-E053-731AD00AA948","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"12192436","version":"1","preferredName":"Transplant Conditioning Type","preferredDefinition":"Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection)._Something distinguishable as an identifiable class based on common qualities.","longName":"12192436v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transplant Conditioning","conceptCode":"C64468","definition":"Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F048BF15-6413-27D7-E053-731AD00A9A42","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-12-20","modifiedBy":"MMADDINENI","dateModified":"2022-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9A37501-33EC-3B45-E053-731AD00A0C8C","latestVersionIndicator":"Yes","beginDate":"2023-04-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-18","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":"4/18/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173179","version":"1","longName":"Treatment","context":"Pediatric Cancer"},{"publicId":"12173207","version":"1","longName":"Stem Cell Transplant","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"SCT_CONDITIONING_TYPE","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"SCT Conditioning Type","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9B2434A-8A21-4560-E053-731AD00ADABD","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":"4/19/23 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}